Among 23 companies, in a very special all digital RESI conference edition, MOWOOT was voted as the best medical device company of the event, and even made 2nd place in the overall rating of most voted companies. RESI GLOBAL CONFERENCE SERIES The Redefining Early Stage Investments (RESI) Conference is an ongoing conference series that has … Continued

MOWOOT non-pharma & non-invasive solution to chronic constipation has won the Audience Award in the Medtech category, the overall Audience Award as the company with the most votes of all 3 categories and also got the 2nd place of the Jury awards in the Medtech category of the EIT Health Catapult at EIT Health Summit. … Continued

usMIMA was awarded a €50.000 grant from EIT Health, which is one of the largest healthcare initiatives worldwide, to help them turn their innovative medical device MOWOOT, a non-pharmacological, non-invasive solution to chronic constipation, into a commercially viable business. usMIMA was one of the 12 projects selected for the EIT Health Spain Head Start and … Continued

usMIMA S.L. winner of the seventh edition of BioEmprenedorXXI (BEXXI) 2014. usMIMA, SubtilisBiomat and Tractivus have been selected as best bio/health companies of the year. Among the finalists were also Kocoon and KeepNeuron. BEXXI is a competitive program focused on the creation of new startups in the health sector, such as: Biotechnology, Biomedicine & Medical … Continued

Have a look at how we worked on our solutions and business model in the invent and implement stages of the d·HEALTH program. During the invent phase we create the first proofs of concept of the solutions for the unmet needs we detected in the clinical immersion. With the proof of concept we help the … Continued